Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly D Sullivan

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Cell Reports|September 23, 2016
Multivalent Chromatin Engagement and Inter-domain Crosstalk Regulate MORC3 ATPaseForest H Andrews, Qiong Tong, Kelly D Sullivan, et al.
Cell Reports|December 28, 2022
IGF1 deficiency integrates stunted growth and neurodegeneration in Down syndromePaula Araya, Kohl T Kinning, Christina Coughlan, et al.
Nature Communications|June 28, 2024
Variegated overexpression of chromosome 21 genes reveals molecular and immune subtypes of Down syndromeMicah G Donovan, Neetha P Eduthan, Keith P Smith, et al.
Iscience|August 13, 2025
Interferon signaling modulates Down syndrome-associated Alzheimer's disease pathology in a mouse modelPaula Araya, Brian Niemeyer, Kyndal Schade, et al.
Elife|January 19, 2023
Trisomy 21 induces pericentrosomal crowding delaying primary ciliogenesis and mouse cerebellar developmentCayla E Jewett, Bailey L McCurdy, Eileen T O'Toole, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2019
Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivityPaula Araya, Katherine A Waugh, Kelly D Sullivan, et al.
Science Advances|June 28, 2023
Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibitionMatthew D Galbraith, Angela L Rachubinski, Keith P Smith, et al.
Cell Reports|November 18, 2020
JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down SyndromeKathryn D Tuttle, Katherine A Waugh, Paula Araya, et al.
Cell|January 10, 2017
Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged LeukemiaKaiwei Liang, Andrew G Volk, Jeffrey S Haug, et al.
Cell Reports|August 9, 2024
Multimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndromeMicah G Donovan, Angela L Rachubinski, Keith P Smith, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Cell Reports|September 23, 2016
Multivalent Chromatin Engagement and Inter-domain Crosstalk Regulate MORC3 ATPaseForest H Andrews, Qiong Tong, Kelly D Sullivan, et al.
Cell Reports|December 28, 2022
IGF1 deficiency integrates stunted growth and neurodegeneration in Down syndromePaula Araya, Kohl T Kinning, Christina Coughlan, et al.
Nature Communications|June 28, 2024
Variegated overexpression of chromosome 21 genes reveals molecular and immune subtypes of Down syndromeMicah G Donovan, Neetha P Eduthan, Keith P Smith, et al.
Iscience|August 13, 2025
Interferon signaling modulates Down syndrome-associated Alzheimer's disease pathology in a mouse modelPaula Araya, Brian Niemeyer, Kyndal Schade, et al.
Elife|January 19, 2023
Trisomy 21 induces pericentrosomal crowding delaying primary ciliogenesis and mouse cerebellar developmentCayla E Jewett, Bailey L McCurdy, Eileen T O'Toole, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2019
Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivityPaula Araya, Katherine A Waugh, Kelly D Sullivan, et al.
Science Advances|June 28, 2023
Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibitionMatthew D Galbraith, Angela L Rachubinski, Keith P Smith, et al.
Cell Reports|November 18, 2020
JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down SyndromeKathryn D Tuttle, Katherine A Waugh, Paula Araya, et al.
Cell|January 10, 2017
Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged LeukemiaKaiwei Liang, Andrew G Volk, Jeffrey S Haug, et al.
Cell Reports|August 9, 2024
Multimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndromeMicah G Donovan, Angela L Rachubinski, Keith P Smith, et al.
Pageof 7